Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation

Leuk Lymphoma. 2005 Dec;46(12):1755-60. doi: 10.1080/10428190500264496.

Abstract

The immune recovery of 66 patients undergoing allogeneic stem cell transplantation with either conventional or non-myeloablative conditioning regimen was studied. Infections post-transplant were enumerated and quantitative immunoglobuilins (IgG, IgA, IgM) and lymphocyte sub-sets 3, 6 and 12 months post-transplant were measured. A significant difference was found in the immunologic recovery of non-myeloablative and conventional ASCT in the patient population. The T-helper cell reconstitution was significantly faster after NMA than conventional transplantation and the recovery of B cells was faster after conventional transplantation. Regarding immunoglobulin levels, a faster recovery of IgM levels after NMA-ASCT and a delayed recovery of IgA levels was observed in both groups. These were accompanied by a significant difference in the frequency and severity of infectious episodes.

MeSH terms

  • Adult
  • Bone Marrow Cells / pathology*
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease / epidemiology
  • Humans
  • Leukemia / therapy
  • Leukocyte Count
  • Lymphocyte Subsets / immunology
  • Lymphoma / therapy
  • Male
  • Middle Aged
  • Stem Cell Transplantation / methods*
  • T-Lymphocytes, Helper-Inducer / immunology
  • Transplantation Conditioning / methods
  • Transplantation, Homologous / immunology